[1]
J. Jalbert, C.-I. Chen, N. Wu, M. Fury, W. Ge, and E. Ruiz, “Patterns Of Hedgehog Inhibitor (HHI) Treatment Interruptions and Reinitiations Among Patients with Basal Cell Carcinoma (BCC) in Real-World Clinical Practice”, J of Skin, vol. 4, no. 6, p. s123, Oct. 2020.